INOTREM
Inotrem S.A. is a biotechnology company specialized in immunotherapy for acute and chronic inflammatory syndromes. The company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Through its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, LR12 (nangibotide), with potential applications in a number of therapeutic indications such as septic shock and myocardial infarction. In paral... lel, Inotrem has also launched another program to develop a new therapeutic modality targeting chronic inflammatory diseases. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide (LR12), with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases.
INOTREM
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2013-03-08
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.inotrem.com
Total Employee:
11+
Status:
Active
Total Funding:
121 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arima Genomics
Arima Genomics is a biotechnology company commercializing a new standard in DNA sequencing.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
VectivBio
VectivBio is a biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Debt Financing - Inotrem
Kreos Capital
Kreos Capital investment in Debt Financing - Inotrem
Bpifrance
Bpifrance investment in Debt Financing - Inotrem
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Series B - Inotrem
Sofinnova Partners
Sofinnova Partners investment in Series B - Inotrem
Invus
Invus investment in Series B - Inotrem
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Inotrem
Andera Partners
Andera Partners investment in Series B - Inotrem
BioMed Invest
BioMed Invest investment in Series B - Inotrem
Andera Partners
Andera Partners investment in Series A - Inotrem
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-24 | Inotrem Bolsters Leadership Team With the Appointment of Sven Zimmermann as New CEO |
Official Site Inspections
http://www.inotrem.com
- Host name: cluster014.ovh.net
- IP address: 213.186.33.87
- Location: Saran France
- Latitude: 47.9531
- Longitude: 1.871
- Timezone: Europe/Paris
- Postal: 45770
